Clinical Trial

Hematological Indices and Sympathetic Block Response in Neuropathic Pain

Study acronym: HINSPAIN
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to evaluate the relationship between hematological inflammatory indices and clinical treatment response in patients with neuropathic pain undergoing sympathetic nerve block procedures as part of routine clinical care. Hematological parameters including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AISI), and red cell distribution width (RDW) will be evaluated before and after treatment. The association between changes in these indices and pain outcomes will be analyzed.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-30
Trial Details
NCT Number NCT07596823
Lead Sponsor Ankara City Hospital Bilkent
Conditions Neuropathic Pain, Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4
Enrollment 120 participants
Start Date 2026-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-29